Woodline Partners’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-208,656
| Closed | -$240K | – | 1059 |
|
|
2025
Q1 | $240K | Sell |
208,656
-4,584
| -2% | -$5.27K | ﹤0.01% | 869 |
|
|
2024
Q4 | $467K | Buy |
+213,240
| New | +$467K | ﹤0.01% | 842 |
|
|
2024
Q3 | – | Sell |
-379,175
| Closed | -$876K | – | 711 |
|
|
2024
Q2 | $876K | Buy |
+379,175
| New | +$876K | 0.01% | 467 |
|
|
2023
Q4 | – | Sell |
-203,783
| Closed | -$7.08M | – | 664 |
|
|
2023
Q3 | $7.08M | Buy |
203,783
+53,783
| +36% | +$1.87M | 0.08% | 261 |
|
|
2023
Q2 | $4.92M | Buy |
150,000
+23,286
| +18% | +$764K | 0.06% | 293 |
|
|
2023
Q1 | $4.24M | Buy |
126,714
+6,701
| +6% | +$224K | 0.06% | 316 |
|
|
2022
Q4 | $3.94M | Sell |
120,013
-8,650
| -7% | -$284K | 0.05% | 351 |
|
|
2022
Q3 | $4.49M | Buy |
128,663
+8,663
| +7% | +$302K | 0.06% | 313 |
|
|
2022
Q2 | $1.47M | Hold |
120,000
| – | – | 0.02% | 479 |
|
|
2022
Q1 | $1.63M | Hold |
120,000
| – | – | 0.03% | 407 |
|
|
2021
Q4 | $2.38M | Buy |
+120,000
| New | +$2.38M | 0.03% | 395 |
|